ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Kripke To President’s Cancer Panel

March 21, 2003

Panel Says NIH Must Devise Means For Early Release Of Trials Data

January 25, 1991

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985

NCI Advisors Approve New Grant Program In Bone Metastasis

April 5, 2002

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985